These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 12857866)

  • 1. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
    Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
    Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
    Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
    Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
    Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
    J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.
    Sangadala S; Metpally RP; Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
    Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
    J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane.
    Suzuki C; Murakami G; Fukuchi M; Shimanuki T; Shikauchi Y; Imamura T; Miyazono K
    J Biol Chem; 2002 Oct; 277(42):39919-25. PubMed ID: 12151385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.
    Shen R; Chen M; Wang YJ; Kaneki H; Xing L; O'keefe RJ; Chen D
    J Biol Chem; 2006 Feb; 281(6):3569-76. PubMed ID: 16299379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1.
    Raju GP; Dimova N; Klein PS; Huang HC
    J Biol Chem; 2003 Jan; 278(1):428-37. PubMed ID: 12393873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.
    Fujii M; Takeda K; Imamura T; Aoki H; Sampath TK; Enomoto S; Kawabata M; Kato M; Ichijo H; Miyazono K
    Mol Biol Cell; 1999 Nov; 10(11):3801-13. PubMed ID: 10564272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
    Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
    J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling.
    Yoshida Y; von Bubnoff A; Ikematsu N; Blitz IL; Tsuzuku JK; Yoshida EH; Umemori H; Miyazono K; Yamamoto T; Cho KW
    Mech Dev; 2003 May; 120(5):629-37. PubMed ID: 12782279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis.
    Nakayama T; Gardner H; Berg LK; Christian JL
    Genes Cells; 1998 Jun; 3(6):387-94. PubMed ID: 9734784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia.
    Horiki M; Imamura T; Okamoto M; Hayashi M; Murai J; Myoui A; Ochi T; Miyazono K; Yoshikawa H; Tsumaki N
    J Cell Biol; 2004 May; 165(3):433-45. PubMed ID: 15123739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.